Showing results (51-60 of 282) with videos related to
Sort By:
Pageof 29
Critical Reviews in Oncology/Hematology|November 21, 2021
Which treatment after first line therapy in NSCLC patients without genetic alterations in the era of immunotherapy?Amelia Insa, Paloma Martín-Martorell, Raimondo Di Liello, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 17, 2025
SEOM-SOGUG clinical guideline for urothelial cancer (2025)Javier Puente, Alejo Rodríguez-Vida, Elena Sevillano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2010
Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumorsJosé Baselga, Andres Cervantes, Erika Martinelli, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 19, 2010
Supportive care for patients with early breast cancerLaura García-Estévez, Ignasi Tusquets, Isabel Alvarez, et al.Clinical Lung Cancer|May 29, 2017
Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC PatientsPaloma Martín Martorell, Marisol Huerta, Amparo Compañ Quilis, et al.Cancer Treatment Reviews|May 14, 2010
Current perspectives of treatment of ductal carcinoma in situLaura G Estévez, Isabel Alvarez, Miguel Ángel Seguí, et al.Cancers|July 9, 2022
Immunological Landscape of HER-2 Positive Breast CancerSantiago Moragon, Cristina Hernando, Maria Teresa Martinez-Martinez, et al.Journal of Cellular Biochemistry|March 25, 2015
MicroRNA Profile in Response to Doxorubicin Treatment in Breast CancerEduardo Tormo, Begoña Pineda, Eva Serna, et al.Familial Cancer|May 22, 2026
Genotypic and phenotypic characteristics of germline TP53 variant carriers: experience from two cancer genetic counseling unitsBeatriz Grau Mirete, Asia Ferrández Arias, Paula Rodríguez Payá, et al.BMC Pharmacology & Toxicology|November 28, 2018
Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinomaMaría José Méndez-Vidal, Áurea Molina, Urbano Anido, et al.Pageof 29